BioSpace News Archive

Assertio Holdings, Inc. announced that it closed its previously announced registered direct of common stock at a purchase price of $0.98 per share for gross proceeds of approximately $34.3 million.

Omnicell, Inc., a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases.

Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced its financial and operational results for the third quarter of its fiscal year 2021, which ended December 31, 2020.

GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the closing of its previously announced registered direct offering of 4,081,633 shares of its common stock, at a purchase price per share of $49.00, for gross proceeds of approximately $200.0 million.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upcoming virtual investor conferences: The Leerink Virtual 10th Annual Global Healthcare Conference on Wednesday, February 24, 2021 at 1:00 p.m. Eastern Time (ET).

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 8,571,429 shares of its common stock at a price to the public of $3.50 per share, for gross proceeds of $30.0 million before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by Corvus

Synaptogenix, Inc. announced that Dr. Alan Tuchman M.D., Chief Executive Officer, and Dr. Daniel Alkon M.D., Chief Scientific Officer, will host a group presentation at the MicroCap Rodeo’s Winter Wonderland Conference on Wednesday, February 17th, 2021 at 11:30 am EDT, and hold one-on-one meetings on February 18th and 19th.

Protein Metrics Inc., a premier provider of mass spectrometry software for protein characterization, announced today a seventh consecutive year of record revenue growth along with annualized bookings from biopharmaceutical customers growing at over 30% over the previous year.

Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (NASDAQ:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, today announced the pricing of its underwritten public offering of 1,100,000 shares of common stock at a public offering price of $25.00 per share.